N. T. Haar

Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type

J. Peterse, M. Vijver, A. Cleton-Jansen, 1999, British Journal of Cancer.

Elevated expression of SerpinA1 and SerpinA3 in HLA‐positive cervical carcinoma

J. Oosting, A Gorter, A. Gorter, 2008, The Journal of pathology.

Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer

H. Morreau, P. Diest, T. Bosse, 2013, Modern Pathology.

Designing a High-Throughput Somatic Mutation Profiling Panel Specifically for Gynaecological Cancers

G. Fleuren, J. Trimbos, T. van Wezel, 2014, PloS one.

SY-1-4 P53 mutations and other genetic changes in invasive and intraductal breast cancer

J. Peterse, M. Vijver, P. Clahsen, 1996 .

Alterations in classical and nonclassical HLA expression in recurrent and progressive HPV‐induced usual vulvar intraepithelial neoplasia and implications for immunotherapy

S. H. van der Burg, E. Jordanova, G. Fleuren, 2014, International journal of cancer.

Different mechanisms of chromosome 16 loss of heterozygosity in well‐ versus poorly differentiated ductal breast cancer

M. J. van de Vijver, A. Cleton-Jansen, C. Cornelisse, 2004, Genes, chromosomes & cancer.

PCR artifacts in LOH and MSI analysis of microdissected tumor cells.

G. Fleuren, A. Cleton-Jansen, C. Cornelisse, 2000, Human pathology.